Propionyl-CoA
Propionyl-CoA is a significant intermediate in the metabolic pathway known as the tricarboxylic acid cycle (TCA cycle) or Krebs cycle. It is derived from the catabolism of odd-chain fatty acids, branched-chain amino acids, and from the side chain of cholesterol.
Structure[edit]
Propionyl-CoA is a Coenzyme A (CoA) derivative in which the terminal sulfhydryl group (-SH) is linked to the carboxyl group (-COOH) of propionic acid through a high-energy thioester bond. The molecule is composed of an adenosine 3',5'-bisphosphate moiety, a pantothenic acid moiety, and a cysteamine moiety.
Metabolism[edit]
Propionyl-CoA is metabolized in a series of reactions known as the propionyl-CoA carboxylase pathway. This pathway converts propionyl-CoA to methylmalonyl-CoA, which is then converted to succinyl-CoA, a key intermediate in the TCA cycle. The conversion of propionyl-CoA to succinyl-CoA requires several enzymes and cofactors, including biotin, adenosylcobalamin, and methylmalonyl-CoA mutase.
Clinical significance[edit]
Defects in the metabolism of propionyl-CoA can lead to several metabolic disorders, including propionic acidemia and methylmalonic acidemia. These disorders are characterized by the accumulation of propionyl-CoA and its metabolites in the body, leading to various symptoms such as developmental delay, intellectual disability, and metabolic acidosis.
See also[edit]
-
Propionyl-Coenzyme A structure
-
Odd-chain fatty acid oxidation
-
Propionyl-CoA
-
Methylcitrate cycle with intermediates and enzymes
-
3-Hydroxypropionic acid 3D model
-
Aspergillus nidulans
-
5H84 structure from the Protein Data Bank
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian